Sharon Amir
Senior Partner
| Email: | [email protected] |
| Fields: | Commercial Transactions; Corporate Law and Governance; Hi-Tech; Mergers and Acquisitions; Private Equity; Public Company Representation; Securities and Capital Markets. |
| Position: | Senior Partner |
| Seniority in position: | Since 1991 |
| Education: | LL.B., Tel Aviv University; LL.M., NYU - New York University (Specializing in Taxation); BA, Philosophy and Political Science, UNSW - University of New South Wales. |
What is the most significant move that you led recently?
Handling the sale of Plus500 to Playtech for $ 750 million.
Representation of Fimi Fund in the acquisition of the control nucleus at Hadera Paper for NIS 360 million.
Representation of Fimi Fund in the acquisition of 51% of Israel Oxygen for NIS 186 million.
Representation in the acquisition of 55% of Amal Me'ever Umeal.
Handling the sale of Plus500 to Playtech for $ 750 million.
Representation of Fimi Fund in the acquisition of the control nucleus at Hadera Paper for NIS 360 million.
Representation of Fimi Fund in the acquisition of 51% of Israel Oxygen for NIS 186 million.
Representation in the acquisition of 55% of Amal Me'ever Umeal.
What are the firm's most significant strengths in your eyes?
First of all, we are a one stop shop, the firm handles practically all the civilian targets line at the highest level. In several areas such as mergers and acquisitions, high tech, insurance and tort we are considered the leading firm in Israel and in others we are among the leading ones, whereas our goal is to become the leaders.